Disinfection of needleless connectors for catheters in one second using a hand-held UV device

October 9, 2024

Background

Central Line-associated Bloodstream Infections (CLABSIs) are deadly bloodstream infections with high mortality and morbidity rates in patients with vascular catheters. In the United States, around 250,000 occur yearly. Of these, about 80,000 occur in intensive care units.

Current Approaches to Disinfection of Needleless Connectors (NC)

Disinfection of NC is performed using 70% isopropanol, chlorhexidine, or both. Alcohol and chlorhexidine disinfectants have several shortcomings in that (1) they only disinfect external surfaces, (2) active disinfection requires active scrubbing of 5 to 15 seconds and a drying time of 5 seconds for isopropanol or 20 seconds for chlorhexidine with scrubbing to disinfect effectively. Rarely, chlorhexidine can cause allergic reactions in some patients.

Use of UV Light as an Approach to Disinfection

Inadequate disinfection of NCs of a peripherally inserted central catheter (PICC) or central venous catheter (CVC) can lead to CLABSIs. Biofilm can form within the intraluminal surface of NC of a PICC or CVC. To address this problem, PuraCath Medical Inc. has developed a product to reduce the risk of bacterial transfer through NCs. The UV-Disinfection System (Firefly) consists of (1) a handheld UV LED system to disinfect; (2) the proprietary neutral displacement, UV-transmissive, NC. A rechargeable lithium-ion battery powers the handheld UV LED device.

Methods

Materials

Proprietary NCs used for these studies were manufactured by PuraCath Medical Inc. and were composed of UV-transmissive cyclic-oleic copolymers. 3M Curos caps for NCs were used as comparators (3M). Female Luer Lock Nonvented Caps (Cat # 11396) were purchased from Qonsina. The Firefly device was manufactured by PuraCath Medical Inc and contained an LED that emits light at a wavelength of 285 nm, with an average power of 45 mW/cm2.

General Procedures

The aseptic technique was used for all experiments. Positive controls were not exposed to UV-C light and negative controls were not inoculated. Controls were run concurrently with Test articles.

Agar Plates for CFU Counting

Agar plates containing media suitable for the growth of each organism were prepared for colony forming units (CFU) counts. S aureus: ATCC Medium 18: Trypticase Soy Agar/Broth; S epidermitis: ATCC Medium 18: Trypticase Soy Agar/Broth; E Coli: ATCC Medium 3: Nutrient agar or nutrient broth; P aeruginosa: ATCC Medium 3: Nutrient agar or nutrient broth; C albicans: Medium 1245: YEPD.

Inoculation of NCs

PuraCath NCs were inoculated with 10 µL of bacterial or fungal suspension at a minimum concentration of 106 CFUs/mL. The initial CFU concentration was verified by drawing serial dilutions of the suspension, plating the diluted samples, incubating the samples, and calculating the resulting CFUs.

Results

We conducted a benchtop study of NC disinfection using Firefly, using 4-log reduction in CFU as success criteria based on US Food and Drug Administration requirements. We tested 22 samples using 5 clinically relevant microbes. Our goal was to achieve a 4-log reduction in CFU with no failures in 22 samples to have 90% confidence and 90% reliability for all targeted microbes using 1 second of UV light exposure.

Table 1: Disinfection of NCs by UV-C irradiation bulk fluid
Organism Positive controls (CFUs) Log reduction in CFUs
S aureus 4.0 x 105 5.5
S epidermidis 4.5 x 105 6.1
E coli 2.1 x 105 5.5
P aeruginosa 6.0 x 104 5.7
C albicans 1.2 x 105 4.6

Discussion

We have demonstrated the efficacy of the Firefly system to disinfect NCs in the laboratory setting. The bacteria and fungi tested are those responsible for most CLABSIs in hospital patients reported to the Centers for Disease Control. The Firefly UV irradiation was effective for all the bacteria tested, and C albicans. The efficacy of the UV-C disinfection of UV-transmissive NC was equivalent to that obtained with alcohol-impregnated caps for the exterior surface.

Conclusions

This benchtop study showed that UV-C disinfection of UV-transmissive NCs using the Firefly device achieved over 4-log reduction in CFUs on the NC’s external and internal surfaces. The disinfection required 1 second of UV irradiation, in contrast to a 15-second alcohol scrub of nonalcohol-impregnated caps. The expectation is that one handheld Firefly device would be used for each patient to avoid the additional step of disinfecting the device when moving from patient to patient.

References

1. Centers for Disease Control and Prevention. National and state healthcare-associated infections report. Accessed March 22, 2024. https://www.cdc.gov/hai/data/portal/progress-report.html

2. Health Care-Associated Infections. National HAI targets & metrics. Accessed March 22, 2024. https://health.gov/hcq/prevent-hai-measures.asp

3. Center for Medicare & Medicaid Services. Hospital-acquired condition reduction program. Accessed March 22, 2024. https://www.cms.gov/medicare/quality/value-based-programs/hospital-acquired-conditions

October 10, 2024
PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced today that it has published the result of its research on its ultraviolet (UV) light-based intravascular catheter connection disinfection system in the American Journal of Infection Control (AJIC), a peer-reviewed scientific journal published by Elsevier on behalf of the Association for Professionals in Infection Control and Epidemiology.
PuraCath Medical Receives 510(k) Clearance for its Needleless Connector for Vascular Access
By puracath August 3, 2021
Device is intended for use primarily by ICU nurses during infusions in patients in a critical care setting. PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced today that it has received 510(k) clearance for its FireFly™ Needleless Connector from the U.S. Food […]
Why We Aren’t Using UV to Disinfect Everything—Yet
By puracath June 16, 2020
Negative perception and costs pose obstacles to a promising technology As the coronavirus pandemic continues, a technology that has existed for over 100 years is getting renewed attention as a promising disinfection tool. Ultraviolet germicidal radiation, which uses short-wavelength UV rays to kill bacteria and viruses, is already used to disinfect the air, water, and […]
PuraCath UV Device Displays a 99.9999% Disinfection of COVID-19 Virus in 1 Second
By puracath April 27, 2020
PuraCath has been partnered and working with a top tier BSL-3 National Laboratory, which has a premiere high containment infectious disease facilities to test its Firefly UV device for the ICU and hospitals with 2019-nCoV (the COVID-19 virus). The preliminary results show that PuraCath’s device has achieved 99.9999% disinfection with SARS-CoV-2 (the virus that is […]
PuraCath FireflyTM Can Kill Deadly Microorganisms with UV Light, Like SARS CoV-2
By puracath March 19, 2020
President Trump has officially declared a national emergency. A novel coronavirus has been identified in Wuhan City, China and has spread worldwide. It has been named SARS CoV-2 (causing disease COVID-19) by WHO. SARS CoV-2 has officially become a global pandemic by WHO. There have already been over 170,000 confirmed cases to date with an […]
By puracath June 19, 2019
JUNE 18, 2019 PuraCath Medical, a venture-backed medical device company based in Silicon Valley, announced today that it has achieved 99.99% disinfection on its vascular access Firefly disinfection technology system with Candida auris (‘superbug’), Staphylococcus aureus, and Candida albicans. “Achieving greater than 4 log disinfection in these virulent microbes with only one second of UV […]
By puracath March 7, 2017
San Francisco, California (March 7, 2017) – PuraCath Medical has published the result of its recent research on its ultraviolet (UV) light-based peritoneal dialysis catheter connection system in Peritoneal Dialysis International (PDI), the official Journal of the International Society for Peritoneal Dialysis. PDI is a major source of knowledge in the field of peritoneal dialysis and aims […]
PuraCath Medical to Present Data on FireFly™ Peritoneal Dialysis Connector Disinfecting System durin
By Larry Yost May 12, 2016
San Francisco, California (May 12, 2016) – Data being presented will support planned introduction of PuraCath Medical’s technology in the European Union. PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it will present data on its next generation version of the FireFly™ […]
PuraCath Medical Presents Data at National Kidney Foundation 2016 Spring Clinical Meetings
By Larry Yost April 28, 2016
Boston, Massachusetts (April 28, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of the FireFly™ Peritoneal Dialysis (PD) Connector Disinfecting System during the National Kidney Foundation’s 2016 Spring Clinical Meetings held […]
PuraCath Medical Presents New Research Data during 36th Annual Dialysis Conference
By Larry Yost February 29, 2016
Company presents study on the effectiveness of next-generation version of the FireFly™ Peritoneal Dialysis Connector Disinfecting System Seattle, Washington (February 29, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of […]
More Posts
Share by: